期刊文献+

胃癌术后患者预后相关因素分析 被引量:4

Related factors for prognosis of gastric cancer patients after operation
下载PDF
导出
摘要 目的探讨性别、年龄、肿瘤临床TNM(T肿瘤大小、N淋巴结转移、M远处转移)分期、化疗及危重病人预警蛋白质(LGT)指纹表达等与胃癌术后患者预后的关系。方法选取2008年6月-2009年6月收治的首次入院并行手术治疗的胃腺癌患者125例,选择性别、年龄、肿瘤临床TNM分期、化疗、LGT蛋白质指纹表达等指标,用单因素和多因素分析的方法研究其对患者生存的影响。结果单因素分析中肿瘤临床TNM分期、LGT丰度、峰型均为胃癌患者术后生存的影响因素。将上述诸相关参数进行COX比例风险回归模型分析,得出TNM分期、LGT蛋白质指纹丰度及峰型是影响胃癌术后患者生存的独立因素,按其影响大小依次排序为:TNM分期、LGT峰型、LGT丰度。结论肿瘤临床TNM分期、LGT峰型、LGT丰度是影响胃癌患者术后生存的独立因素。 Objective To study the correlation between gender and age of gastric cancer patients,clinical TNM stage,chemotherapy,lost goodwill target(LGT) protein fingerprints and prognosis of gastric cancer patients after operation.Methods One hundred and twenty-five patients with gastric adenocardnoma admitted to our hospital in June 2008-June 2009 were enrolled in this study.Effect of their gender,age,TNM stage,chemotherapy,and LGT protein fingerprints on their survival time after operation was analyzed by single and multiple variable analyses.Results Single factor analysis showed that TNM stage,peak types and abundance of LGT protein fingerprints were the significant prognostic factors of the survival time of gastric cancer patients after operation.Multiple factor analysis showed that TNM stage,abundance and peak types of LGT protein fingerprints were the independent factors for the survival time of gastric cancer patients after operation in Cox ratio risk regression model.Conclusion TNM stage,abundance and peak types of LGT are the independent prognostic factors for the survival time of gastric cancer patients after operation.
出处 《军医进修学院学报》 CAS 2011年第6期584-587,共4页 Academic Journal of Pla Postgraduate Medical School
关键词 胃癌 生存分析 LGT蛋白质指纹 Gastric Cancer Survival Analysis LGT Fingerprints
  • 相关文献

参考文献7

二级参考文献43

  • 1王洁,刘叙仪,蒋薇,梁莉.Telomerase activity and expression of the telomerase catalytic subunit gene in non small cell lung cancer: correlation with decreased apoptosis and clinical prognosis[J].Chinese Medical Journal,2000(11):25-30. 被引量:8
  • 2张万岱,陈治水,危北海.慢性胃炎的中西医结合诊治方案(草案)[J].中国中西医结合杂志,2005,25(2):172-175. 被引量:497
  • 3邢福成,王殿昌.胃癌根治术预后临床病理因素分析[J].齐鲁肿瘤杂志,1997,4(2):121-123. 被引量:9
  • 4Yamamura Y, Nakajima T, Ohta K, et al. Determining prognostic factors for gastric cancer using the regression tree method [ J ]. Gastric Cancer, 2002,5 (4): 201-207.
  • 5徐光炜 张天泽 徐光炜.胃癌[M].张天泽,徐光炜.肿瘤学(中册)[C].天津:科学技术出版社,1993.1447.
  • 6Bozzetti F, Bonfanti G, Morabito A, et al. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection [J]. Surg Gynecol Obster,1986,162(3 ) :229-234.
  • 7Kang JH, Han JY, Hong YS, et al. Neoadjuvant chemotherapy in patients with locally advanced gastric cancer [C]. 3rd Int. Gastric Cancer Cong., Seoul, 1999:250.
  • 8Kim JP. Surgical results with immunochemotherapy [C]. In:Kim JP, Min JS, Mok YJ, eds. Proceeding of the 3rd International Gastric Cancer Congress, Seoul: Monduzzi Editore, 1999:3-9.
  • 9Popiela T. The role of chemoimmunotherapy in gastric cancer patients treatment: result from Polish Gastric Cancer Study [C]. 3rd Int. Gastric Cancer Cong., Seoul: Monduzzi Editore, 1999:23.
  • 10Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer [J]. Br J Surg, 1997,84(12): 1651-1664.

共引文献114

同被引文献44

  • 1陈建新,吴黎敏.肥胖对腹腔镜辅助胃癌根治术临床效果的影响[J].消化肿瘤杂志(电子版),2011,3(3):141-143. 被引量:4
  • 2杨娜,黄昌明,林涛,郑朝辉,李平,谢建伟,王家镔,林建贤.胃癌腹腔镜手术与开腹手术安全性及远期疗效比较的Meta分析[J].消化肿瘤杂志(电子版),2011,3(3):144-150. 被引量:16
  • 3Yoshimura F,Inaba K,Kawamura Y. Clinical outcome and clinico-pathological characteristics of recurrence after laparoscopic gastrectomy for advanced gastric Cancer[J].{H}DIGESTION,2011,(03):184-190.
  • 4Levitsky LL,Misra M,Boepple PA. Adolescent obesity and bariatric surgery[J].Curr Opin Endocrinol Diabetes Obes,2009,(01):37-44.
  • 5Wild S,Roglic G,Green A. Global prevalence of diabetes:estimates for the year 2000 and projections for 2030[J].{H}DIABETES CARE,2004,(05):1047-1053.
  • 6Jiang J. Systematic review of feasibility and safety of laparoscopic gastrectomy for gastric cancer[J].Chinese-German Journal of Clinical Oncology,2012,(04):199-205.
  • 7Etoh T,Inomata M,Shiraishi N. Minimally invasive approaches for gastric cancer-Japanese experiences[J].{H}Journal of Surgical Oncology,2012.
  • 8Lee JH, Kim KM, Cheong JH, et al. Current management and future strategies of gastric cancer [ J ] . Yonsei Med J, 2012, 53 ( 2 ) : 248 -257.
  • 9Iwauchi T, Tanaka H, Yamazoe S, et al. Identification of HLA- A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer [ ] ] . Cancer Sei, 2011, 102 ( 4 ) : 683-689.
  • 10Perret R, Ronchese F. Memory T cells in cancer immunotherapy : which CD8 T-cell population provides the best protection against tumours? [ J ] . Tissue Antigens, 2008, 72 ( 3 ) : 187-194.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部